세계의 초음파 프로브 소독 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 방법별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Ultrasound Probe Disinfection Market Summary

The global ultrasound probe disinfection market size was estimated at USD 785.68 million in 2024 and is projected to reach USD 1,883.60 million by 2033, growing at a CAGR of 10.29% from 2025 to 2033. The demand for ultrasound probe disinfection is increasing due to the rising incidence of hospital-acquired infections (HAIs), leading to heightened awareness of infection control protocols and a growing reliance on ultrasound imaging for diagnostics and treatment across various medical specialties.

The increasing demand for ultrasound procedures is expected to be a major driver of the ultrasound probe disinfection market. Data from NHS England published in March 2024 shows that ultrasound procedures for NHS patients in England rose from approximately 0.78 million in December 2022 to 0.91 million in November 2023. This increasing volume of ultrasound procedures highlights the growing necessity for efficient disinfection solutions, supporting market expansion in the coming years.

In addition, the increasing burden of healthcare-associated infections (HAIs) is projected to significantly contribute to the growth of the ultrasound probe disinfection market. According to data released by the European Centre for Disease Prevention and Control, a European Union Agency, in May 2024, approximately 4.3 million hospitalized patients across the EU and European Economic Area (EEA) are affected by HAIs annually. These infections pose serious health risks and also place a significant strain on healthcare systems. As ultrasound procedures become more widespread in clinical settings, the risk of cross-contamination through inadequately disinfected probes becomes a critical concern. This growing burden of HAIs, coupled with stringent regulatory guidelines, is driving the adoption of advanced ultrasound probe disinfection solutions to ensure patient safety and reduce the incidence of HAIs.

Global Ultrasound Probe Disinfection Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ultrasound probe disinfection market report based on product, method, end-use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
  • Automated Reprocessors
  • UV-C Disinfectors
  • Manual Reprocessors/Soaking Stations
  • Ultrasound Probe Storage Cabinets
• Consumables
  • Consumables, By Formulations
  • Disinfectant Liquids
  • Disinfectant Wipes
  • Disinfectant Sprays
  • Consumables, By Detergent
  • Enzymatic Detergents
  • Non-enzymatic Detergents
• Service
• Method Outlook (Revenue, USD Million, 2021 - 2033)
• High-Level Disinfection
• Intermediate Level Disinfection/Low-Level Disinfection
• End-use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals and Clinics
• Diagnostic Imaging Centers
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Method
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Ultrasound Probe Disinfection Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for ultrasound procedures
    • 3.2.1.2. Rising burden of healthcare associated infections
    • 3.2.1.3. Increasing use of semi-critical ultrasound probes in oncology, cardiology, and reproductive health driving shift to high-level disinfection
    • 3.2.1.4. Regulations & guidelines recommending HLD for semi-critical and critical devices
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Product recalls
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Emerging technologies within the ultrasound probe disinfection space
    • 3.2.3.2. Expansion opportunities into emerging economies
    • 3.2.3.3. Favorable government initiatives
    • 3.2.3.4. Expansion and adoption of UV-C-based chemical-free disinfection
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Shortage of reprocessing workers and associated training
  • 3.2.5. Commercial channels for ultrasound probe disinfection products
• 3.3. Ultrasound Probe Disinfection Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Ultrasound Probe Disinfection Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Ultrasound Probe Disinfection Market Product Movement Analysis
• 4.3. Global Ultrasound Probe Disinfection Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.1. Automated reprocessors
      • 4.4.1.1.1. Automated reprocessors market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.2. UV-C disinfectors
      • 4.4.1.2.1. UV-C disinfectors market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.3. Manual reprocessors/soaking stations
      • 4.4.1.3.1. Manual reprocessors/soaking stations market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.4.1.4. Ultrasound probe storage cabinets
      • 4.4.1.4.1. Ultrasound probe storage cabinets market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.1. Formulations
      • 4.5.1.1.1. Formulations market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.1. Disinfectant liquids
          • 4.5.1.1.1.1.1. Disinfectant liquids market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.2. Disinfectant wipes
          • 4.5.1.1.1.2.1. Disinfectant wipes market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.1.1.3. Disinfectant sprays
          • 4.5.1.1.1.3.1. Disinfectant sprays market estimates and forecasts for 2021 to 2033 (USD Million)
    • 4.5.1.2. Detergents
      • 4.5.1.2.1. Detergents market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.1. Enzymatic detergents
          • 4.5.1.2.1.1.1. Enzymatic detergents market estimates and forecasts for 2021 to 2033 (USD Million)
        • 4.5.1.2.1.2. Non-enzymatic detergents
          • 4.5.1.2.1.2.1. Non-enzymatic detergents market estimates and forecasts for 2021 to 2033 (USD Million)
• 4.6. Service
  • 4.6.1. Service market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Ultrasound Probe Disinfection Market: Method Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Ultrasound Probe Disinfection Market Method Movement Analysis
• 5.3. Global Ultrasound Probe Disinfection Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 5.4. High-Level Disinfection
  • 5.4.1. High-level disinfection market estimates and forecasts for 2021 to 2033 (USD Million)
• 5.5. Intermediate Level Disinfection/Low-Level Disinfection
  • 5.5.1. Intermediate level disinfection/low-level disinfection market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 6. Ultrasound Probe Disinfection Devices: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Ultrasound Probe Disinfection Market End Use Movement Analysis
• 6.3. Global Ultrasound Probe Disinfection Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospitals and Clinics
  • 6.4.1. Hospitals and clinics market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.5. Diagnostic Imaging Centers
  • 6.5.1. Diagnostic imaging centers market estimates and forecasts for 2021 to 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 7. Ultrasound Probe Disinfection Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada market estimates and forecasts, 2021 - 2033
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Competitive scenario
    • 7.4.1.3. Regulatory framework
    • 7.4.1.4. Reimbursement scenario
    • 7.4.1.5. UK market estimates and forecasts, 2021 - 2033
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. Germany market estimates and forecasts, 2021 - 2033
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. France market estimates and forecasts, 2021 - 2033
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. Italy market estimates and forecasts, 2021 - 2033
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Spain market estimates and forecasts, 2021 - 2033
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Norway market estimates and forecasts, 2021 - 2033
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. Japan market estimates and forecasts, 2021 - 2033
  • 7.5.2. India
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. India market estimates and forecasts, 2021 - 2033
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. China market estimates and forecasts, 2021 - 2033
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. Australia market estimates and forecasts, 2021 - 2033
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE market estimates and forecasts, 2021 - 2033
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Global Key company market share analysis, 2024
  • 8.3.4. ASP (Fortive)
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Nanosonics
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. CIVCO Medical Solutions
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Tristel Plc
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Ecolab
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Germitec
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. CS Medical LLC
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Steelco S.p.A.
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. STERIS
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. IMA-X
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. EDM Medical Solutions
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. GE HealthCare
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. UV Smart
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
  • 8.3.17. Lumicare
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives
• 8.4. Heat Map Analysis/ Company Market Position Analysis
• 8.5. Estimated Company Market Share Analysis, 2024
• 8.6. List of Other Key Market Players